Status:
COMPLETED
Estrogen and Graft Atherosclerosis Research Trial (EAGER)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Arteriosclerosis
Eligibility:
FEMALE
45-75 years
Phase:
PHASE3
Brief Summary
To determine if postmenopausal hormone replacement therapy in women following coronary bypass surgery would reduce the occurrence of graft occlusion and delay the development of graft atherosclerosis.
Detailed Description
BACKGROUND: Coronary atherosclerosis is a major cause of death in women in the United States. Although coronary artery bypass surgery decreases symptomatic and clinical evidence of ischemia, it does ...
Eligibility Criteria
Postmenopausal women who had undergone coronary artery bypass graft.
Key Trial Info
Start Date :
August 1 1996
Trial Type :
INTERVENTIONAL
End Date :
July 1 2002
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000605
Start Date
August 1 1996
End Date
July 1 2002
Last Update
February 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.